Matinas BioPharma
MTNB
MTNB
31 hedge funds and large institutions have $6.6M invested in Matinas BioPharma in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-8
Holders Change %
-20.51%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
10
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
Morgan Stanley
New York
|
-$319K |
2 |
Goldman Sachs
New York
|
-$186K |
3 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$157K |
4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$138K |
5 |
Millennium Management
New York
|
-$137K |